|
09/03/2010 05:31 PM
|
|
Roche to cut jobs after setbacks for drugs
|
Roche confirmed speculation about significant job cuts to tailor its spending to tougher market conditions, but said it would not give details until later this year
|
|
09/03/2010 02:20 AM
|
|
Silverfleet looks to auction US asset
|
The private equity owner of Sterigenics, a US medical device sterilisation group, has hired JPMorgan to run an auction of the company that it hopes will raise about $800m
|
|
09/02/2010 11:36 PM
|
|
Cancer drug trial halted as patients fall ill
|
Tests in Ireland abandoned after three of 12 people receiving the treatment suffer seizures and are admitted to hospital. The Irish Medicines Board has launched an investigation into the incident
|
|
09/02/2010 08:00 PM
|
|
Scientists closer to malaria cure
|
Scientists have cured malaria in mice with a single dose of a new drug, the journal Science reports
|
|
08/31/2010 07:33 PM
|
|
Sanofi-Aventis/Genzyme
|
The troubled US biotech believes it is undervalued by the French drugmaker – but it cannot afford to be too choosy
|
|
08/31/2010 07:27 PM
|
|
Hunger for Genzyme deal grows keener
|
Genzyme's removal of some of its takeover defences – including a poison pill and staggered directors' appointments – makes the US biotech group more vulnerable to a hostile bid
|
|
08/30/2010 06:14 PM
|
|
Genzyme rejects Sanofi takeover
|
Genzyme rejected a takeover offer from Sanofi-Aventis, calling the French pharmaceutical group's $69 a share bid 'opportunistic' and 'unrealistic'
|
|
08/29/2010 09:39 PM
|
|
Sanofi steps up Genzyme pursuit
|
Sanofi-Aventis steps up its pursuit of Genzyme, outlining publicly its interest in a deal as the French pharmaceuticals group inches closer to making a hostile offer for the US biotech
|
|
08/27/2010 11:20 PM
|
|
Southern Cross rejects TowerBrook offer
|
The troubled care home group declines to enter further negotiations with TowerBrook amid an indicative takeover offer by the UK-based private equity company
|
|
08/25/2010 06:34 PM
|
|
Scientists create liver cells from skin
|
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells
|
|
08/23/2010 08:08 PM
|
|
Challenges ahead for Sanofi chief
|
Chris Viehbacher needs to reinvigorate the French group's research and development pipeline for the production of new innovative drugs to replace existing ones going off patent
|
|
08/22/2010 10:48 PM
|
|
AstraZeneca had internal debate on drug data
|
Documents made public during litigation on the pharmaceutical group's antipsychotic drug Seroquel highlight apparent efforts by the group to communicate favourable data selectively to boost prescriptions
|
|
08/22/2010 08:14 PM
|
|
Conflicted interests
|
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines
|
|
08/22/2010 05:43 PM
|
|
Four Seasons close to renegotiating its debt
|
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan
|
|
08/20/2010 09:16 PM
|
|
East offers prescription for west's plans
|
Western companies have been tempted by strong sales of their older medicines, as well as a willingness by the Chinese authorities to authorise western prices for innovative drugs
|
